LifeMD Statistics
Total Valuation
LifeMD has a market cap or net worth of $388.58 million. The enterprise value is $379.28 million.
Important Dates
The last earnings date was Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LifeMD has 45.45 million shares outstanding. The number of shares has increased by 17.81% in one year.
| Current Share Class | 45.45M |
| Shares Outstanding | 45.45M |
| Shares Change (YoY) | +17.81% |
| Shares Change (QoQ) | +8.00% |
| Owned by Insiders (%) | 15.34% |
| Owned by Institutions (%) | 35.38% |
| Float | 36.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 126.67 |
| PS Ratio | 1.54 |
| Forward PS | 1.45 |
| PB Ratio | -989.36 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 27.87 |
| P/OCF Ratio | 25.27 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.62 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 27.20 |
Financial Position
The company has a current ratio of 0.82
| Current Ratio | 0.82 |
| Quick Ratio | 0.73 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.80 |
| Interest Coverage | -3.19 |
Financial Efficiency
Return on equity (ROE) is -2,243.07% and return on invested capital (ROIC) is -20.23%.
| Return on Equity (ROE) | -2,243.07% |
| Return on Assets (ROA) | -6.88% |
| Return on Invested Capital (ROIC) | -20.23% |
| Return on Capital Employed (ROCE) | -58.45% |
| Revenue Per Employee | $762,239 |
| Profits Per Employee | -$45,065 |
| Employee Count | 307 |
| Asset Turnover | 3.46 |
| Inventory Turnover | 10.53 |
Taxes
In the past 12 months, LifeMD has paid $402,000 in taxes.
| Income Tax | 402,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.26% in the last 52 weeks. The beta is 2.23, so LifeMD's price volatility has been higher than the market average.
| Beta (5Y) | 2.23 |
| 52-Week Price Change | -8.26% |
| 50-Day Moving Average | 5.91 |
| 200-Day Moving Average | 5.57 |
| Relative Strength Index (RSI) | 71.46 |
| Average Volume (20 Days) | 2,232,843 |
Short Selling Information
The latest short interest is 5.34 million, so 11.75% of the outstanding shares have been sold short.
| Short Interest | 5.34M |
| Short Previous Month | 6.17M |
| Short % of Shares Out | 11.75% |
| Short % of Float | 14.53% |
| Short Ratio (days to cover) | 7.67 |
Income Statement
In the last 12 months, LifeMD had revenue of $234.01 million and -$13.83 million in losses. Loss per share was -$0.33.
| Revenue | 234.01M |
| Gross Profit | 205.90M |
| Operating Income | -7.43M |
| Pretax Income | -23.07M |
| Net Income | -13.83M |
| EBITDA | -5.86M |
| EBIT | -7.43M |
| Loss Per Share | -$0.33 |
Full Income StatementBalance Sheet
The company has $34.39 million in cash and $25.10 million in debt, giving a net cash position of $9.29 million or $0.20 per share.
| Cash & Cash Equivalents | 34.39M |
| Total Debt | 25.10M |
| Net Cash | 9.29M |
| Net Cash Per Share | $0.20 |
| Equity (Book Value) | -392,754 |
| Book Value Per Share | -0.05 |
| Working Capital | -10.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $15.38 million and capital expenditures -$1.44 million, giving a free cash flow of $13.94 million.
| Operating Cash Flow | 15.38M |
| Capital Expenditures | -1.44M |
| Free Cash Flow | 13.94M |
| FCF Per Share | $0.31 |
Full Cash Flow StatementMargins
Gross margin is 87.99%, with operating and profit margins of -3.18% and -4.58%.
| Gross Margin | 87.99% |
| Operating Margin | -3.18% |
| Pretax Margin | -4.17% |
| Profit Margin | -4.58% |
| EBITDA Margin | -2.51% |
| EBIT Margin | -3.18% |
| FCF Margin | 5.96% |
Dividends & Yields
LifeMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.81% |
| Shareholder Yield | -17.81% |
| Earnings Yield | -3.56% |
| FCF Yield | 3.59% |
Analyst Forecast
The average price target for LifeMD is $11.17, which is 30.64% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.17 |
| Price Target Difference | 30.64% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on October 14, 2020. It was a reverse split with a ratio of 0.2:1.
| Last Split Date | Oct 14, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.2:1 |
Scores
LifeMD has an Altman Z-Score of 0.41 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.41 |
| Piotroski F-Score | 4 |